Clinical Trials Directory

Trials / Recruiting

RecruitingNCT03455478

Shanghai Eye Study for Adults

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
1,000,000 (estimated)
Sponsor
Shanghai Eye Disease Prevention and Treatment Center · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Accepted

Summary

Blindness and visual impairment severely impact the visual health and life quality of people, particularly the 2.566 million senior citizens aged at 65 and above in Shanghai. The main reason is uncorrected refractive error, of which, 62.1% can be solved through refractive correction. For this reason, the uncorrected refractive errors of 154,000 senior citizens in Shanghai can be taken as a priority among the public health issues to prevent blindness. Now, with the aim to reduce the prevalence rate of blindness and visual impairment, it is planned to establish a public health service mechanism in terms of refractive error screening and correction for the elderly by relying on Shanghai's three-level (city-district-community) eye diseases prevention network, using proper refractive correction technology, and moving related services forward to communities in order to screen, identity, and correct blindness and visual impairment caused by refractive errors as early as possible.

Conditions

Interventions

TypeNameDescription
DEVICEspectaclesdispending spectacles for uncorrected refractive error

Timeline

Start date
2016-01-01
Primary completion
2019-11-30
Completion
2026-11-30
First posted
2018-03-06
Last updated
2022-05-24

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03455478. Inclusion in this directory is not an endorsement.